Showing results (861-870 of 1,193) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|July 7, 2026
A Bayesian Optimal Interval Design Considering Efficacy and Toxicity in Early Phase Basket TrialsTomoyuki Kakizume, Kentaro Takeda, Masataka Taguri, et al.Pharmaceutical Statistics|June 5, 2026
CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized TrialsFanni Zhang, Kristine Broglio, Michael Sweeting, et al.Pharmaceutical Statistics|May 19, 2026
A Knowledge Base of Designs and Statistical Methods for Adaptive Clinical Dose-Finding TrialsRob Kessels, Yongxi Long, Rene Spijker, et al.Pharmaceutical Statistics|May 19, 2026
Fiducial-Based Statistical Intervals for Bounded Bioanalytical Data Using the Kumaraswamy DistributionJorge Quiroz, Jingwei Xiong, Satrajit Roychoudhury, et al.Pharmaceutical Statistics|December 11, 2020
A class of goodness-of-fit test for the additive hazards model with case-cohort dataYongxiu Cao, Jichang YuPharmaceutical Statistics|July 5, 2023
Defining estimands for efficacy assessment in single arm phase 1b or phase 2 clinical trials in oncology early developmentStefan Englert, François Mercier, Elizabeth A Pilling, et al.Pharmaceutical Statistics|August 14, 2026
A Cautionary Note on Regional Consistency Evaluation With Multiple Primary Endpoints in Multiregional Clinical TrialsGosuke HommaPharmaceutical Statistics|August 28, 2026
Robustness of the Pairwise-Fitting Approach Under Missing at Random Dropout: A Case and Simulation StudyDries De Witte, Geert Verbeke, Thomas Neyens, et al.Pharmaceutical Statistics|September 11, 2026
Applying the Promising Zone Method to Biomarker-Based Adaptive Designs: A Word of CautionJingzhao Wang, Ruobing Li, Jun Zhao, et al.Pharmaceutical Statistics|September 4, 2026
Accelerated Stability Studies: A Frequentist-Bayesian Hybrid Simulation Approach Implemented in the AccelStab R PackageBernard G Francq, Nikolaos Giannelos, Raymundo Sanchez, et al.Pageof 120